Tevogen (TVGN) Selling, General & Administrative (2022 - 2026)
Tevogen (TVGN) reported Selling, General & Administrative of $2.27 million for Q1 2026, down 68.4% from $7.16 million a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Tevogen (TVGN) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Tevogen's Selling, General & Administrative came in at $10.13 million, down 51.7% year-over-year; for FY2025, it was $15.03 million, down 33.3% from FY2024.
- Selling, General & Administrative has a four-year compound annual growth rate of 201.7% (FY2021 to FY2025).
- By year, Selling, General & Administrative came in at $22.53 million in FY2024 (+407.5%), $4.44 million in FY2023 (+365.8%), $953,083 in FY2022 (+425.3%) and $181,421 in FY2021.
- The Q1 2026 figure ranks as the lowest quarterly Selling, General & Administrative since Q4 2023.
- Year over year, Selling, General & Administrative has now declined in each of the last five quarters, with growth averaging 90.1% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q1 2024 (growth of 790.9%); the low point was Q1 2026 (a decline of 68.4%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $2.5 million (Q4 2025), $2.62 million (Q3 2025) and $2.74 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Tevogen | 27.39 Mn | 24.42 Mn | - | 2.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.27 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 7.16 Mn |
| Dec 31, 2024 | 6.53 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 4.47 Mn |
| Mar 31, 2024 | 8.71 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 977,109.00 |
| Dec 31, 2022 | 212,787.00 |
| Sep 30, 2022 | 198,832.00 |
| Jun 30, 2022 | 258,585.00 |
| Mar 31, 2022 | 282,879.00 |
API Access
Tevogen Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TVGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TVGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TVGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();